Results 31 to 40 of about 148,391 (263)
Advances in the Immunology and Genetics of Leprosy
Frontiers in Immunology, 2020 Leprosy, a disease caused by the intracellular parasite Mycobacterium leprae or Mycobacterium lepromatosis, has affected humans for more than 4,000 years and is a stigmatized disease even now.
Zihao Mi, Hong Liu, Furen Zhang
doaj +1 more source
Illness perceptions of leprosy-cured individuals in Surinam with residual disfigurements – “I am cured, but still I am ill” [PDF]
, 2016 Objective Leprosy has rarely been the subject of health psychology research despite its substantial impact. Our aim was to explore illness perceptions in patients and their health care providers in Surinam.
Kaptein, Ad A. +4 more
core +1 more source
On the Origin of Leprosy [PDF]
Science, 2005 Leprosy, a chronic human disease with potentially debilitating neurological consequences, results from infection with Mycobacterium leprae . This unculturable pathogen has undergone extensive reductive evolution, with half of its genome now occupied by pseudogenes.
Monot, Marc +21 more
openaire +5 more sources
BMC Infectious Diseases, 2019 Background Leprosy is an ancient infectious disease with a global annual incidence that has plateaued above 200,000 new cases since over a decade. New strategies are required to overcome this stalemate.
Nimer Ortuno-Gutierrez +13 more
doaj +1 more source
Putting Indian christianities into context: Biographies of christian conversion in a leprosy colony [PDF]
, 2014 Gandhian and Hindutva-inspired discourses around conversions to Christianity in India over-simplify the historical nexus of relations between missionaries, converts and the colonial state.
Staples, J
core +1 more source
BMC Health Services Research, 2017 Background Leprosy has a wide range of clinical and socio-economic consequences. India, Indonesia and Nepal contribute significantly to the global leprosy burden. After integration, the health systems are pivotal in leprosy service delivery.
A. Tiwari +6 more
doaj +1 more source
Clinical Microbiology Reviews, 1988 Leprosy affects over 10 million people in the world. The disease is a model of graded cell-mediated immunity, in this case to the causative organism, Mycobacterium leprae. The clinical manifestations are due to (i) bacterial progression, (ii) immunologic responses of the host, (iii) peripheral nerve damage due to either or both bacterial progression ...
R C, Hastings +3 more
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1895 Spokane, Washington, Nov. 22, 1895. To the Editor: —My experience with lepers would point to Dr. McDougal's cases as being undoubtedly leprosy. In the Sandwich Islands many cases can be found to disprove Dr. Ashmead's statement that "if they were lepers the mother would have been infected too," Dr. Geo. L.
openaire +2 more sources
EXPERIMENTAL STUDY OF SPECIFIC ACTIVITY OF 1,3-DIAZINON-4 COMPOUND PYaTdl DERIVATIVE IN VIVO
Журнал микробиологии, эпидемиологии и иммунобиологии, 2016 Aim. Study anti-leprosy activity of a 1.3-diazinon-4 compound derivative under the laboratory code PYaTd 1 on the model of intra-plantar infection of mice and evaluate the character of its antibacterial effect. Materials and methods.
S. A. Luzhnova +5 more
doaj +1 more source
Journal of Dermatological Treatment, 2023 Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram +2 more
doaj +1 more source